Literature DB >> 24427701

"High frequency presbycusis"-is there an earlier onset?

B Arvin1, N Prepageran1, R Raman1.   

Abstract

The objective of this study is to determine whether presbycusis occurs much earlier than previously believed if the high frequency (above 8 kHz) are included. Tertiary referral center (a teaching University). This is a cross-sectional observational study. Healthy adults from 20 to 49 years of age who had essentially normal hearing were included into the study. They were subjected to high frequency pure tone audiometry (until 16 kHz). Participants were grouped based on age ranges of 10 years (e.g., 20-29, 30-39, and 40-49) and the presence of symmetrical high frequency sensor neural hearing loss were documented. There is a significant presence of symmetrical high frequency sensor neural hearing loss (not attributed to any known risk factors) as early as from the age group of 40 to 49 years. Seven of 43 participants (16%) from age group of 20 to 29 years and 12 of 24 participants (50%) from age group of 30 to 39 years had significant high frequency hearing loss. High frequency hearing loss (high frequency Presbycusis) may occur much earlier than previously believed.

Entities:  

Keywords:  Earlier onset; Presbycusis

Year:  2011        PMID: 24427701      PMCID: PMC3889367          DOI: 10.1007/s12070-011-0356-x

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  12 in total

1.  [Cochlear hypoxia and mtDNA deletion: possible correlated factors to cause presbycusis].

Authors:  P Dai; S Jiang; R Gu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2000-12

Review 2.  Mutation in mitochondrial DNA as a cause of presbyacusis.

Authors:  James O Pickles
Journal:  Audiol Neurootol       Date:  2004 Jan-Feb       Impact factor: 1.854

Review 3.  Presbycusis: a human temporal bone study of individuals with downward sloping audiometric patterns of hearing loss and review of the literature.

Authors:  Erik G Nelson; Raul Hinojosa
Journal:  Laryngoscope       Date:  2006-09       Impact factor: 3.325

4.  Asymmetric sensorineural hearing loss evaluation with T2 FSE-MRI in a public hospital.

Authors:  D J Verret; Robert T Adelson; Robert J Defatta
Journal:  Acta Otolaryngol       Date:  2006-07       Impact factor: 1.494

5.  Cellular pattern and nerve supply of the human organ of Corti.

Authors:  G Bredberg
Journal:  Acta Otolaryngol       Date:  1968       Impact factor: 1.494

6.  Gender affects audiometric shape in presbyacusis.

Authors:  J Jerger; R Chmiel; B Stach; M Spretnjak
Journal:  J Am Acad Audiol       Date:  1993-01       Impact factor: 1.664

7.  Histopathological observations of presbycusis.

Authors:  F Suga; J R Lindsay
Journal:  Ann Otol Rhinol Laryngol       Date:  1976 Mar-Apr       Impact factor: 1.547

8.  Correlation of cochlear blood supply with mitochondrial DNA common deletion in presbyacusis.

Authors:  Pu Dai; Weiyan Yang; Sichang Jiang; Rui Gu; Huijun Yuan; Dongyi Han; Weiwei Guo; Juyang Cao
Journal:  Acta Otolaryngol       Date:  2004-03       Impact factor: 1.494

9.  [Mitochondrial DNA4977 deletions associated with human presbycusis].

Authors:  W Han; D Han; S Jiang
Journal:  Zhonghua Er Bi Yan Hou Ke Za Zhi       Date:  2000-12

10.  Hearing loss in aging.

Authors:  Giovana dos Santos Baraldi; Lais Castro de Almeida; Alda Cristina de Carvalho Borges
Journal:  Braz J Otorhinolaryngol       Date:  2007 Jan-Feb
View more
  9 in total

1.  Osteogenesis imperfecta and hearing loss: an analysis of patients attended at a benchmark treatment center in southern Brazil.

Authors:  Andressa Colares da Costa Otavio; Adriane Ribeiro Teixeira; Temis Maria Félix; Letícia Petersen Schimidt Rosito; Sady Selaimen da Costa
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-31       Impact factor: 2.503

2.  Aging and Direct-to-Consumer Prescription Drug Television Ads: The Effects of Individual Differences and Risk Presentation.

Authors:  Amie C O'Donoghue; Mihaela Johnson; Helen W Sullivan; Sarah Parvanta; Sarah Ray; Brian G Southwell
Journal:  J Health Commun       Date:  2019-04-23

Review 3.  3 Tesla magnetic resonance imaging noise in standard head and neck sequence does not cause temporary threshold shift in high frequency.

Authors:  Elizabeth Yenn Lynn Lim; Ing Ping Tang; Mohammadreza Peyman; Norlisah Ramli; Prepageran Narayanan; Raman Rajagopalan
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-10       Impact factor: 2.503

4.  An Ototoxicity Grading System Within a Mobile App (OtoCalc) for a Resource-Limited Setting to Guide Grading and Management of Drug-Induced Hearing Loss in Patients With Drug-Resistant Tuberculosis: Prospective, Cross-Sectional Case Series.

Authors:  Cara Hollander; Natalie Schellack; Karin Joubert
Journal:  JMIR Mhealth Uhealth       Date:  2020-01-14       Impact factor: 4.773

Review 5.  Impact of Hearing Loss on Geriatric Assessment.

Authors:  Christiane Völter; Lisa Götze; Stefan Dazert; Rainer Wirth; Jan Peter Thomas
Journal:  Clin Interv Aging       Date:  2020-12-30       Impact factor: 4.458

6.  Impact of drug-resistant tuberculosis treatment on hearing function in South African adults: Bedaquiline versus kanamycin.

Authors:  Katijah Khoza-Shangase; Marina Prodromos
Journal:  S Afr J Commun Disord       Date:  2021-01-26

7.  Loss of audiovisual facilitation with age occurs for vergence eye movements but not for saccades.

Authors:  Martin Chavant; Zoï Kapoula
Journal:  Sci Rep       Date:  2022-03-15       Impact factor: 4.996

8.  High-Frequency Hearing Loss Is Associated With Anxiety and Brain Structural Plasticity in Older Adults.

Authors:  Wen Ma; Yue Zhang; Xiao Li; Siqi Liu; Yuting Gao; Jing Yang; Longji Xu; Hudie Liang; Fuxin Ren; Fei Gao; Yao Wang
Journal:  Front Aging Neurosci       Date:  2022-03-10       Impact factor: 5.750

9.  Benefits of Cochlear Implantation in Middle-Aged and Older Adults.

Authors:  Christiane Völter; Lisa Götze; Imme Haubitz; Stefan Dazert; Jan Peter Thomas
Journal:  Clin Interv Aging       Date:  2020-09-07       Impact factor: 4.458

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.